Reference
- Department of Health. The UK Strategy for Rare Diseases, 2013. [cited 2021 October 12]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/260562/UK_Strategy_for_Rare_Diseases.pdf
References
- Thompson MA, Majhail NS, Wood WA, et al. Social media and the practicing hematologist: Twitter 101 for the busy healthcare provider. Curr Hematol Malig Rep. 2015;10(4):405–412.
- Pemmaraju N, Utengen A, Gupta V, et al. Rare cancers and social media: analysis of Twitter metrics in the first 2 years of a rare-disease community for myeloproliferative neoplasms on social media-#MPNSM. Curr Hematol Malig Rep. 2017;12(6):598–604.
- Dol J, Tutelman PR, Chambers CT, et al. Health researchers’ use of social media: scoping review. J Med Internet Res. 2019;21(11):e13687.
References
- Kelly J, Sadeghieh T, Adeli K. Peer review in scientific publications: benefits, critiques, & a survival guide. EJIFCC 2014;25(3):227–243.
- Nature. Transparent peer review at nature communications. Nat Commun 2015;6:10277.
- Walach H, Klement RJ, Aukema W. Retraction: the safety of COVID-19 vaccinations—we should rethink the policy [Vaccines 2021, 9, 693]. Vaccines 2021; 9:729.
- Hardwicke TE, Goodman SN. How often do leading biomedical journals use statistical experts to evaluate statistical methods? The results of a survey. PLoS One 2020;15(10):e0239598.
Reference
- International Society for Medical Publication Professionals. ISMPP CMPP™ Overview. [cited 2021 October 11]. Available from: https://www.ismpp.org/overview.
References
- Predatory journals could damage the legitimacy of scientific publishing. July 29, 2019. [cited 2021 Sept 30]. Available from: https://phys.org/news/2019-07-predatory-journals-legitimacy-scientific-publishing.html
- AMWA–EMWA–ISMPP joint position statement on predatory publishing. AMWA J. 2019;34(3):112–113.
- American Medical Writers Association, European Medical Writers Association, International Society for Medical Publication Professionals. AMWA–EMWA–ISMPP joint position statement on predatory publishing. Curr Med Res Opin. 2019;35(9):1657–1658.
- Predatory Publishing. Will publishing in predatory journals harm your CV? [cited 2021 October 1]. Available from: https://predatory-publishing.com/will-publishing-in-predatory-journals-harm-your-cv/
- Zakout YM-A. Predatory publishers/journals in medical sciences: how to avoid, stop, and what to do after being scammed by them?. J Gastrointest Canc. 2020;51:782–787.
- Ibrahim S, Saw A. The perils of predatory journals and conferences. Malays Orthop J. 2020;14(2):1–6. doi: https://doi.org/10.5704/MOJ.2007.003
- Richtig G, Berger M, Lange-Asschenfeldt B, et al. Problems and challenges of predatory journals. J Eur Acad Dermatol Venereol. 2018;32(9):1441–1449.
- Beall’s List of Potential Predatory Journals and Publishers. Potential predatory scholarly open-access journals. [Updated 2021 Feb 5; cited 2021 Oct 1]. Available from: https://beallslist.net/standalone-journals/
- Cabells International. Predatory Reports and Journalytics services. [cited 2021 October 1]. Available from: https://www2.cabells.com/
- Medical Publishing Insights & Practices. Enhanced Publication Options Navigator. [cited 2021 October 1]. Available from: https://www.mpip-initiative.org/transparencymatters/epon.html
- The Directory of Open Access Journals. Find open access journals & articles. [cited 2021 October 1]. Available from: https://doaj.org/
Reference
- American Medical Writers Association, European Medical Writers Association & International Society for Medical Publication Professionals. AMWA-EMWA-ISMPP joint position statement on medical publications, preprints, and peer review. Current Med Res Opinion. 2021;37(5):861–866.
Reference
- Christel M. Pharm Exec’s Top 50 Companies 2020. Pharmaceutical Executive 40:6. [cited 2021 October 8]. Available from: https://www.pharmexec.com/view/pharm-execs-top-50-companies-2020
Reference
- Plain Language Summaries (PLS) of Publications: Perspectives that will shape the future: https://www.pathlms.com/ismpp/courses/24746/webinars/15307
References
- Smith MR, Saad F, Chowdhury S, et al. Apalutamide treatment and metastasis-free survival in prostate cancer. N Engl J Med. 2018;378:1408–1418.
- Hussain M, Fizazi K, Saad F, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med. 2018;378:2465–2474.
- Drilon A, Oxnard GR, Tan DSW, et al. Efficacy of selpercatinib in RET fusion–positive non–small-cell lung cancer. N Engl J Med. 2020;383:813–824.
- Wirth LJ, Sherman E, Robinson B, et al. Efficacy of selpercatinib in RET-altered thyroid cancers. N Engl J Med. 2020;383:825–835.
- Gonzalez-Martin A, Pothuri B, Vergote I, et al. Niraparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2019;381:2391–2402.
- Ray-Coquard I, Pautier P, Pignata S, et al. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer. N Engl J Med. 2019;381:2416–2428.
- Coleman RL, Fleming GF, Brady MF, et al. Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer. N Engl J Med. 2019;381:2403–2415.
- De Bono J, Mateo J, Fizazi K, et al. Olaparib for metastatic castration-resistant prostate cancer. N Engl J Med. 2020;382:2091–2102.
References
- Shepherd A, Draghi N, Burd G. An exploratory analysis of online activity surrounding simultaneous publication and congress presentation. Curr Med Res Opin 2018;34s1:30.
- Oska S, Lerma E, Topf J. A picture is worth a thousand views: a triple crossover trial of visual abstracts to examine their impact on research dissemination. J Med Internet Res 2020;22:e22327.
References
- Zong Q, Xie, Y, Tuo, R et al. The impact of video abstract citation counts: evidence from a retrospective cohort study of new journal of physics. Scientometrics 2019;119:1715–1727.
- Bredbenner K, Simon SM. Video abstracts and plain language summaries are more effective than graphical abstracts and published abstracts. PLoS One 2019;14(11):e0224697.
- Leading publishers. OpenMD.com. [cited 2021 Aug]. Available from: https://openmd.com/directory/journals.
References
- Hill G, Setlur S, Bueno E, et al. Evaluation of QR code use in in-person versus virtual congresses for posters in the COVID-19 era: are we reaching our audiences? 2021 Virtual US Meeting of the International Society for Medical Publication Professionals (ISMPP; April 12–14, 2021): poster number 30.
- Borte M, Anderson-Smits C, Hermann C. Update on real-world use of facilitated subcutaneous immunoglobulin and immune globulin subcutaneous (human) 20% solution in patients with immunodeficiencies: poster extracts from the 19th Biennial Meeting of the European Society for Immunodeficiencies. Expert Rev Clin Immunol. 2021;17(sup1):7–8.
- Allen G, Du P, Khair K, et al. Addressing unmet needs in rare bleeding disorders: selected poster extracts of recent research in hemophilia A and von Willebrand disease presented at the 14th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) (Feb 3–5, 2021; virtual congress). Expert Rev Hematol. 2021;14(sup1):1–18.
References
- Abdill RJ, Blekhman R. Tracking the popularity and outcomes of all bioRxiv preprints. Elife. 2019;8:e45133.
- American Medical Writers Association, European Medical Writers Association and International Society for Medical Publication Professionals. AMWA-EMWA-ISMPP joint position statement on medical publications, preprints, and peer review. CMRO. 2021;37(5):861–866.
References
- O’Donoghue SI, Baldi BF, Clark SJ, Darling AE, Hogan JM, Kaur S, et al. Visualization of biomedical data. Ann Rev Biomed Data Sci. 2018;1(1):275–304.
References
- Freeman H, Macdonald S, Baronikova S, et al. Original abstracts from the 2021 European Meeting of ISMPP. Curr Med Res Opinion. 2021;37(sup1):21–39.
- The top 20 pharma companies by 2020 revenue. [cited 2021 Sep 01]. Available from: https://www.fiercepharma.com/special-report/top-20-pharma-companies-by-2020-revenue.
- About us. [cited 2021 Oct 08]. Available from: https://openpharma.blog/about-us/
- Lens.org [cited 2021 Oct 08]. Available from: https://www.lens.org/
- Ovid – Embase. [cited 2021 Oct 08]. Available from: https://ovidsp.dc2.ovid.com/
- Simple Query Tool. [cited 2021 Oct 08]. Available from: https://unpaywall.org/products/simple-query-tool
References
- Rosenberg A, Baróniková S, Feighery L, et. al. 2021. Open pharma recommendations for plain language summaries of peer-reviewed medical journal publications. Curr Med Res Opinion. 37(11):2015–2016.
- A company’s approach to developing publication plain language summaries. [cited 2021 Oct 4]. https://ismpp-newsletter.com/2021/08/10/a-companys-approach-to-developing-publication-plain-language-summaries/.
- Arnstein, L., et. al. 2020. Original abstracts from the 16th Annual Meeting of ISMPP. Curr Med Res Opin. 36(Suppl. 1):5–22.
Reference
- Rosenberg A, Baronikova S, Feighery L, et al. Open pharma recommendations for plain language summaries of peer-reviewed medical journal publications. Curr Med Res Opinion. 2021;37(11):2015–2016.
References
- Helson R, Gorman D, Clarke B, et al. Is it time to improve the format of scientific posters? Original abstracts from the 2020 European Meeting of ISMPP. Curr Med Res Opinion. 2020;36(Suppl. 1):23–33.
- Richardson M, Pyke E, Patel R, et al. Enhancing oral presentations: can animated videos engage viewers post-congress? Original abstracts from the 15th Annual Meeting of ISMPP. Curr Med Res Opinion. 2019;35(Suppl. 2):5–29.
- Bowling A, Cantu D, Meo A, et al. Poster format preferences among attendees at a major medical congress. Original abstracts from the 16th Annual Meeting of ISMPP. Curr Med Res Opinion. 2020;36(Suppl. 1):5–22.
- Pyke E, de Courcy S, Smart L, et al. Reform and enhancement of scientific posters: what was the extent of innovation in 2020? Original abstracts from the 2021 European Meeting of ISMPP. Curr Med Res Opinion. 2021;37(Suppl. 1):21–39.
Reference
- McKinnon C, Philippon V, Maritsch F, et al. A review process for scientific publications to protect the privacy of clinical study participants. 2021 European Meeting of the International Society of Medical Publication Professionals, 26-27 Jan 2021, Poster #22.